It is known that blacks have a high rate of hepatitis C and a low response to therapy, but Dr. Zobair Younossi of Inova Fairfax Hospital in Virginia reported at a liver disease conference that the population also does not spontaneously clear the virus as often as other racial or ethnic groups. Another expert said the key may be genetic and linked to a single nucleotide polymorphism in the IL28b gene that affects both therapy response and clearance rates.

Related Summaries